$SSOK
Sunstock, Inc.

2023 Q2 Form 10-Q Financial Statement

#000149315223017042 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $3.158M $3.340M $3.207M
YoY Change -3.44% 2.8% -16.02%
Cost Of Revenue $3.124M $3.293M $3.102M
YoY Change -2.41% 3.72% -15.47%
Gross Profit $34.19K $46.49K $104.5K
YoY Change -51.05% -36.84% -29.41%
Gross Profit Margin 1.08% 1.39% 3.26%
Selling, General & Admin $20.23K $62.05K $14.60K
YoY Change -62.33% 88.77% -63.12%
% of Gross Profit 59.17% 133.47% 13.97%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $55.00 $55.00 $50.00
YoY Change -77.08% -84.72% -76.19%
% of Gross Profit 0.16% 0.12% 0.05%
Operating Expenses $28.46K $70.30K $24.17K
YoY Change -54.73% 67.22% -54.21%
Operating Profit $5.728K -$23.81K $80.36K
YoY Change -17.94% -175.42% -15.66%
Interest Expense -$42.64K $1.443K $130.9K
YoY Change -3054.95% -96.49% 349.33%
% of Operating Profit -744.41% 162.88%
Other Income/Expense, Net -$166.2K $12.16K
YoY Change 63.73% -82.95%
Pretax Income -$160.5K -$11.65K -$3.600M
YoY Change 69.75% -111.32% -1829.67%
Income Tax $800.00
% Of Pretax Income
Net Earnings -$160.5K -$11.65K -$3.601M
YoY Change 69.75% -111.32% -1843.46%
Net Earnings / Revenue -5.08% -0.35% -112.29%
Basic Earnings Per Share -$0.03 $0.00
Diluted Earnings Per Share -$0.03 $0.00 -$0.81
COMMON SHARES
Basic Shares Outstanding 4.816M shares 4.816M shares 4.126M shares
Diluted Shares Outstanding 4.836M shares 4.816M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.880K $4.650K $16.69K
YoY Change -65.61% -87.57% -44.68%
Cash & Equivalents $9.884K $4.646K $16.69K
Short-Term Investments
Other Short-Term Assets $17.75K $18.96K $5.160K
YoY Change 223.32% 161.88% -8.83%
Inventory $1.798M $1.816M $1.752M
Prepaid Expenses $17.75K $18.96K $5.155K
Receivables
Other Receivables
Total Short-Term Assets $1.826M $1.840M $1.774M
YoY Change 22.51% 18.87% 24.15%
LONG-TERM ASSETS
Property, Plant & Equipment $313.00 $369.00 $424.00
YoY Change -54.7% -98.42% -67.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $3.164K $7.414K $11.54K
YoY Change -83.74% -68.18% -57.5%
TOTAL ASSETS
Total Short-Term Assets $1.826M $1.840M $1.774M
Total Long-Term Assets $3.164K $7.414K $11.54K
Total Assets $1.829M $1.848M $1.785M
YoY Change 21.14% 17.58% 22.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.631K
YoY Change -99.2%
Accrued Expenses $450.3K $472.6K $454.9K
YoY Change -14.04% -14.03% 2984.27%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $62.50K $6.000K
YoY Change -100.0% -70.29% -96.08%
Long-Term Debt Due $6.690K $5.870K $5.050K
YoY Change 95.04% 122.35% 172.97%
Total Short-Term Liabilities $493.3K $577.2K $502.3K
YoY Change -41.06% -27.76% -33.13%
LONG-TERM LIABILITIES
Long-Term Debt $143.3K $144.1K $145.0K
YoY Change -2.22% -2.2% -18.75%
Other Long-Term Liabilities $0.00
YoY Change -100.0%
Total Long-Term Liabilities $143.3K $144.1K $145.0K
YoY Change -4.09% -6.66% -23.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $493.3K $577.2K $502.3K
Total Long-Term Liabilities $143.3K $144.1K $145.0K
Total Liabilities $636.6K $721.4K $647.3K
YoY Change -35.46% -24.34% -31.2%
SHAREHOLDERS EQUITY
Retained Earnings -$66.09M -$65.93M -$65.92M
YoY Change 6.16% 5.87%
Common Stock $502.00 $481.00 $481.00
YoY Change 21.84% 16.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.192M $1.126M $1.138M
YoY Change
Total Liabilities & Shareholders Equity $1.829M $1.848M $1.785M
YoY Change 21.14% 17.58% 22.63%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$160.5K -$11.65K -$3.601M
YoY Change 69.75% -111.32% -1843.46%
Depreciation, Depletion And Amortization $55.00 $55.00 $50.00
YoY Change -77.08% -84.72% -76.19%
Cash From Operating Activities -$29.74K -$68.55K -$68.45K
YoY Change -58.52% 36.95% -23.43%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 34.98K $56.50K 52.00K
YoY Change -44.48% -1.4% -36.66%
NET CHANGE
Cash From Operating Activities -29.74K -$68.55K -68.45K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 34.98K $56.50K 52.00K
Net Change In Cash 5.240K -$12.05K -16.45K
YoY Change -160.3% 125.34%
FREE CASH FLOW
Cash From Operating Activities -$29.74K -$68.55K -$68.45K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001559157
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Other Liability Current Related And Nonrelated Party Status Extensible Enumeration
OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4 us-gaap Other Liability Current Related And Nonrelated Party Status Extensible Enumeration
OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q1 SSOK Noncash Extinguishment Of Debt
NoncashExtinguishmentOfDebt
usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-54830
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
SUNSTOCK, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-1856372
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
111 Vista Creek Circle
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Sacramento
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95835
CY2023Q1 dei City Area Code
CityAreaCode
916
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
860-9622
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock.
CY2023Q1 dei Trading Symbol
TradingSymbol
SSOK.
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4815857 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4646 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16691 usd
CY2023Q1 SSOK Inventory Coins Current
InventoryCoinsCurrent
1001398 usd
CY2022Q4 SSOK Inventory Coins Current
InventoryCoinsCurrent
950637 usd
CY2023Q1 SSOK Inventory Precious Metals Current
InventoryPreciousMetalsCurrent
815096 usd
CY2022Q4 SSOK Inventory Precious Metals Current
InventoryPreciousMetalsCurrent
801022 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
18963 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5155 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
1840103 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1773505 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
369 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
424 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7045 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11114 usd
CY2023Q1 us-gaap Assets
Assets
1847517 usd
CY2022Q4 us-gaap Assets
Assets
1785043 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
501826 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
480137 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7045 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11114 usd
CY2023Q1 us-gaap Debt Current
DebtCurrent
5866 usd
CY2022Q4 us-gaap Debt Current
DebtCurrent
5047 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
62500 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
577237 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
502298 usd
CY2023Q1 us-gaap Long Term Loans Payable
LongTermLoansPayable
144134 usd
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
144953 usd
CY2023Q1 us-gaap Liabilities
Liabilities
721371 usd
CY2022Q4 us-gaap Liabilities
Liabilities
647251 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1500000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1500000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4815857 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4815857 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4815857 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4815857 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
481 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
481 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
67053289 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
67053289 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65927624 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65915978 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1126146 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1137792 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1847517 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1785043 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3339884 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3248983 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
3293393 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
3175367 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
46491 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
73616 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
62052 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
32495 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
374 usd
CY2023Q1 us-gaap Other Expenses
OtherExpenses
8248 usd
CY2022Q1 us-gaap Other Expenses
OtherExpenses
9173 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
70300 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
42042 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-23809 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
31574 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
14075 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
45257 usd
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
30250 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
1443 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
1443 usd
CY2023Q1 SSOK Interest Expenses Related Party
InterestExpensesRelatedParty
469 usd
CY2022Q1 SSOK Interest Expenses Related Party
InterestExpensesRelatedParty
2745 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
12163 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
71319 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11646 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
102893 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-11646 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
102893 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4815857 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4126387 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
514911 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
102893 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
617804 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1137792 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1137792 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-11646 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-11646 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1126146 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1126146 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-11646 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
102893 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
14075 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
45257 usd
CY2023Q1 us-gaap Depreciation
Depreciation
55 usd
CY2022Q1 us-gaap Depreciation
Depreciation
355 usd
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
30250 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
50761 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
65367 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
13808 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1584 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
21690 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-10841 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-68545 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-50051 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
56500 usd
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
57300 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
56500 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
57300 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12045 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7249 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16691 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30168 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4646 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
37417 usd
CY2022Q1 SSOK Noncash Extinguishment Of Debt
NoncashExtinguishmentOfDebt
30250 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_843_eus-gaap--UseOfEstimates_zdXY5QfXdzj6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_z3BiE3UspC01">USE OF ESTIMATES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed and consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made by the Company’s management include realizability and valuation of inventories and value of stock-based transactions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zH0XOrqEtKXf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zam2ikRIneTh">CONCENTRATION OF RISK</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high quality banking institutions. The Company did not have cash balances in excess of the Federal Deposit Insurance Corporation limit as of March 31, 2023 and December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
14075 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
45257 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q1 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2022Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65927624 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
58460 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
58460 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
58091 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
58036 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
369 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
424 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
55 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
355 usd
CY2023Q1 SSOK Accrued Court Decision Current
AccruedCourtDecisionCurrent
260308 usd
CY2022Q4 SSOK Accrued Court Decision Current
AccruedCourtDecisionCurrent
260308 usd
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
130000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
131500 usd
CY2023Q1 SSOK Accrued Audit Fees Current
AccruedAuditFeesCurrent
34118 usd
CY2022Q4 SSOK Accrued Audit Fees Current
AccruedAuditFeesCurrent
8089 usd
CY2023Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
36326 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
36326 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4631 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
15879 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
14436 usd
CY2023Q1 SSOK Accrued Interest Payable Related Party
AccruedInterestPayableRelatedParty
16645 usd
CY2022Q4 SSOK Accrued Interest Payable Related Party
AccruedInterestPayableRelatedParty
16176 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8550 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8671 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
501826 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
480137 usd
CY2023Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
36326 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
14155 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
8940 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
8940 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
8940 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
8940 usd
CY2023Q1 SSOK Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
200405 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
250320 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
100320 usd
CY2023Q1 us-gaap Loans Payable
LoansPayable
150000 usd
CY2023Q1 us-gaap Loans Payable Current
LoansPayableCurrent
5866 usd
CY2023Q1 us-gaap Long Term Loans Payable
LongTermLoansPayable
144134 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1500000000 shares

Files In Submission

Name View Source Status
ssok-20230331_cal.xml Edgar Link unprocessable
0001493152-23-017042-index-headers.html Edgar Link pending
0001493152-23-017042-index.html Edgar Link pending
0001493152-23-017042.txt Edgar Link pending
0001493152-23-017042-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ssok-20230331.xsd Edgar Link pending
ssok-20230331_def.xml Edgar Link unprocessable
ssok-20230331_lab.xml Edgar Link unprocessable
ssok-20230331_pre.xml Edgar Link unprocessable